These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Retinoic acid negatively regulates p34cdc2 expression during human neuroblastoma differentiation. Gaetano C; Matsumoto K; Thiele CJ Cell Growth Differ; 1991 Oct; 2(10):487-93. PubMed ID: 1751405 [TBL] [Abstract][Full Text] [Related]
44. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Lasorella A; Iavarone A; Israel MA Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653 [TBL] [Abstract][Full Text] [Related]
45. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells. Schwartz EL; Blair OC; Sartorelli AC Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046 [TBL] [Abstract][Full Text] [Related]
46. Investigations of mechanisms of drug-induced changes in gene expression: N-methylformamide-induced changes in synthesis of the M(r) 72,000 constitutive heat shock protein during commitment of HL-60 cells to granulocyte differentiation. Beere HM; Morimoto RI; Hickman JA Cancer Res; 1993 Jul; 53(13):3034-9. PubMed ID: 8319210 [TBL] [Abstract][Full Text] [Related]
47. Schedule-dependent sphinganine potentiation of retinoic acid-induced differentiation, cell growth inhibition, and nucleophosmin translocation in a human leukemia cell line (HL-60). Hui EK; Yang YH; Yung BY Exp Hematol; 1992 May; 20(4):454-61. PubMed ID: 1568462 [TBL] [Abstract][Full Text] [Related]
48. Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation. Rao JY; Hurst RE; Bales WD; Jones PL; Bass RA; Archer LT; Bell PB; Hemstreet GP Cancer Res; 1990 Apr; 50(8):2215-20. PubMed ID: 2317809 [TBL] [Abstract][Full Text] [Related]
49. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Olsson IL; Breitman TR; Gallo RC Cancer Res; 1982 Oct; 42(10):3928-33. PubMed ID: 6286101 [TBL] [Abstract][Full Text] [Related]
50. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells. Hsieh TC; Ng C; Wu JM Biochem Mol Biol Int; 1995 Oct; 37(3):499-506. PubMed ID: 8595390 [TBL] [Abstract][Full Text] [Related]
51. Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/MRI cells. Imaizumi M; Breitman TR Cancer Res; 1988 Dec; 48(23):6733-8. PubMed ID: 3180083 [TBL] [Abstract][Full Text] [Related]
52. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake. Yen A; Albright KL Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017 [TBL] [Abstract][Full Text] [Related]
53. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Yen A; Varvayanis S Exp Cell Res; 1994 Sep; 214(1):250-7. PubMed ID: 8082728 [TBL] [Abstract][Full Text] [Related]
54. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Del Bino G; Li X; Traganos F; Darzynkiewicz Z Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535 [TBL] [Abstract][Full Text] [Related]
55. Differential regulation of protein kinase C isoenzymes during sphinganine potentiation of retinoic acid-induced granulocytic differentiation in human leukemia HL-60 cells. Yung BY; Hui EK Biochem Biophys Res Commun; 1993 Nov; 196(3):1390-400. PubMed ID: 8250895 [TBL] [Abstract][Full Text] [Related]
56. Blast maturity and CD34 expression determine the effects of the differentiating agents KH1060 and 9-cis-retinoic acid on the differentiation and clonogenicity of non-M3 acute myeloid leukaemia cells. Pallis M; Turzanski J; Russell NH Leukemia; 1998 Nov; 12(11):1741-8. PubMed ID: 9823949 [TBL] [Abstract][Full Text] [Related]
57. Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells. Carter CA; Pogribny M; Davidson A; Jackson CD; McGarrity LJ; Morris SM Anticancer Res; 1996; 16(1):17-24. PubMed ID: 8615604 [TBL] [Abstract][Full Text] [Related]
58. Induction of HL-60 leukemia cell differentiation by the novel antifolate 5,10-dideazatetrahydrofolic acid. Sokoloski JA; Beardsley GP; Sartorelli AC Cancer Res; 1989 Sep; 49(17):4824-8. PubMed ID: 2758415 [TBL] [Abstract][Full Text] [Related]
59. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide. Pellegrini R; Mariotti A; Tagliabue E; Bressan R; Bunone G; Coradini D; Della Valle G; Formelli F; Cleris L; Radice P Cell Growth Differ; 1995 Jul; 6(7):863-9. PubMed ID: 7547508 [TBL] [Abstract][Full Text] [Related]
60. Effects of retinoic acid versus dimethyl sulfoxide on Friend erythroleukemia cell growth. I. Cell proliferation, RNA content, and protein content. Traganos F; Bueti C; Darzynkiewicz Z; Melamed MR J Natl Cancer Inst; 1984 Jul; 73(1):193-204. PubMed ID: 6588224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]